Organigram Global Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.960
+0.110 (5.95%)
At close: Oct 7, 2025, 4:00 PM EDT
1.990
+0.030 (1.53%)
Pre-market: Oct 8, 2025, 7:17 AM EDT
Organigram Global Market Cap
Organigram Global has a market cap or net worth of $262.07 million as of October 8, 2025. Its market cap has increased by 37.21% in one year.
Market Cap
262.07M
Enterprise Value
288.43M
1-Year Change
37.21%
Ranking
Category
Stock Price
$1.96
Market Cap Chart
Since May 21, 2019, Organigram Global's market cap has decreased from $1.01B to $262.07M, a decrease of -74.18%. That is a compound annual growth rate of -19.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 247.90M | 41.82% |
| Dec 31, 2024 | 174.80M | 64.44% |
| Dec 29, 2023 | 106.30M | -57.67% |
| Dec 30, 2022 | 251.10M | -51.98% |
| Dec 31, 2021 | 522.90M | 151.76% |
| Dec 31, 2020 | 207.70M | -45.73% |
| Dec 31, 2019 | 382.70M | -62.29% |
| May 21, 2019 | 1.01B | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |